An article about strategy for extending half life in vivo

In compound optimization stage, “reduce lipophilicity” is mantra for chemists. High lipophilicity compound tend to be metabolically unstable, promiscuous and binding many off targets. To reduce lipophilicity is important strategy for drug discovery process but it is not always suitable strategy. Researchers from Genentech report their useful experience in JMC lett. You can find the